Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spanning Phase 1 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Lung Cancer
• Lymphoma
• Mesothelioma of Pleura
• Solid Tumor

Drugs mentioned

• T3011

Snippet

Sponsor: ImmVira Pharma Co. Ltd | Conditions: Advanced Solid Tumor, Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN